Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
29%(2 trials)

Phase Distribution

Ph phase_4
4
57%
Ph phase_2
1
14%
Ph phase_3
2
29%

Phase Distribution

0

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
2(28.6%)
Phase 4Post-market surveillance
4(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(7)

Detailed Status

Completed7

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (14.3%)
Phase 32 (28.6%)
Phase 44 (57.1%)

Trials by Status

completed7100%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_2

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

NCT00270296
completedphase_4

Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults

NCT00449436
completedphase_4

A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV

NCT00082394
completedphase_4

Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects

NCT00960622
completedphase_3

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

NCT00043888
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT00270296Phase 2

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

Completed
NCT00449436Phase 4

Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults

Completed
NCT00082394Phase 4

A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV

Completed
NCT00960622Phase 4

Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects

Completed
NCT00043888Phase 3

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

Completed
NCT00405925Phase 3

FREE Study: Efficacy and Toxicity of Trizivir

Completed
NCT00127972Phase 4

2NN & CHARM Long-Term Follow-up Study

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7